‘Gutsy’ Ride for Cancer Research
Two generous individuals who tandem-cycled 3072 kilometres from Perth to Adelaide over 32 consecutive days, are helping Flinders cancer researchers in their quest to see patients with oesophageal and gastric cancers live longer.
Bassett Smith and Nga Phan raised more than $16,000 for cancer research at Flinders as part of their ‘Gutsy-3000’ fundraising ride. The ride was inspired by Bassett’s sister Carmel Thompson who has been treated at Flinders for gastrointestinal cancer for the past two years.
Cancer researcher Dr Amitesh Roy, who is a senior medical oncologist and lecturer at the Flinders Medical Centre and Flinders University, is preparing to put the funds towards an exciting new clinical trial for patients with curable and early-stage oesophageal and gastro-oesophageal junction cancers.
The trial, which already has 15 enrolled patients, involves them receiving immunotherapy treatment as an intravenous drug in addition to the standard chemotherapy and radiotherapy regimen given prior to their surgery.
Immunotherapy is a type of cancer treatment that works by boosting a person’s own immune system to fight cancer. While it is often used to treat melanoma, lung, kidney and head and neck cancers, its use is relatively new when it comes to oesophageal and gastric cancers.
“At present, concurrent chemotherapy and radiotherapy given prior to surgery is successful in the killing of cancer cells in about 20 to 30 per cent of cases, but we want to see if the addition of immunotherapy can improve this rate and eventually patient’s survival,” Dr Roy explains.
He will investigate biomarkers to predict a patient’s prognosis and treatment response in the new clinical trial in the hope of identifying the patients that are most likely to benefit from the combination treatment.
“Oesophageal and stomach cancers are uncommon and difficult to treat cancers and unfortunately chemotherapy, radiotherapy and surgery have difficult side effects that go with that and can alter patient’s quality of life and lead to a long recovery,” Dr Roy says.
“And sadly, despite all this, there’s still a 50 to 60 per cent chance the cancer will return within three to five years.
“This biomarker work will add to our ability to understand this cancer further, assess its response to novel immunotherapy treatment and potentially help select patients who are likely to benefit from the chemo-immuno-radiotherapy combination.”
Dr Roy is extremely grateful to Bassett and Nga, and all those who supported them in their fundraising efforts, for giving hope to patients with this disease at Flinders and elsewhere.
“I’m very grateful to Bassett and Nga for the huge effort they have put themselves through – both physically and mentally – to take on a challenge like this.
“Their fundraising is supporting research that takes big steps towards better outcomes for patients with this difficult to treat cancer, which is so important in our quest to see our patients live longer.”
Research Update: Positive Outlook for Sleep Apnea Surgery
Findings from a recent Flinders University study have found that an airway surgery can substantially reduce sleep disruptions and improve the lives of patients who suffer from sleep apnea.
Buying Hope” for South Australians with MND
Research and clinical trials exploring new treatments for Motor Neurone Disease (MND) will soon be underway at Flinders Medical Centre with the appointment of a new MND Fellow.
Heart care key to long term health of cancer survivors
New research out of Flinders has revealed cancer survivors require more care, awareness and management of other health conditions – in particular cardiovascular disease – to help them live longer after cancer treatment.
Virtual reality simulator for eye surgery arrives at Flinders
Trainee eye surgeons across South Australia will be able to practice delicate cataract surgery before they step into the operating theatre with the arrival of a new virtual reality simulator at Flinders Medical Centre.
Simonds Homes partners with Flinders Foundation
Simonds Homes is delighted to announce its partnership with Flinders Foundation and looks forward to working alongside their team to raise money through the sale of a new Simonds home.
Riding For My Research
When Flinders University cancer researcher Dr Ashley Hopkins jumped on his bike to join the 2019 SA Discovery Tour, he was overwhelmed by the support those riding alongside him gave to his research.
Targeted Treatments for Triple Negative Breast Cancer
Thanks to generous funding from Tour de Cure, riders and supporters in 2019, an international research project is hoping to uncover the ‘magic bullet’ for treating Triple Negative Breast Cancer – one of the most aggressive and fatal forms of breast cancer.
32 new health and medical research projects… thanks to you!
At a time when the focus on health and medical research has never been greater, 32 exciting new projects across the Flinders medical precinct have received funding in Flinders Foundation’s annual Health Seed Grant Round.
Rachel’s dream is to improve therapies to treat, and ultimately cure, multiple myeloma.
“Multiple myeloma is incurable, that’s something we’d obviously like to change.”
Protein discovery paves way for new multiple myeloma treatments
Multiple myeloma patients with the poorest prognosis are set to benefit from promising new research